Showing results (161-170 of 319) with videos related to

Sort By:
Pageof 32
Blood Advances|June 17, 2026
Functional analysis of germline RUNX1 variants identified in individuals with suspected familial platelet disorderAna Catarina Menezes, Natalie T Deuitch, Aidan Pintuff, et al.
Cancer|March 14, 2007
Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experienceJames A Talcott, Pamela Spain, Jack A Clark, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|November 30, 2011
Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancerColleen L Doçi, Tanmayi P Mankame, Alexander Langerman, et al.
Cancer|September 18, 2008
Perceived family history risk and symptomatic diagnosis of prostate cancer: the North Carolina Prostate Cancer Outcomes studyPamela Spain, William R Carpenter, James A Talcott, et al.
Cancer Causes & Control : CCC|September 25, 2009
Race, healthcare access and physician trust among prostate cancer patientsYoung Kyung Do, William R Carpenter, Pamela Spain, et al.
Genes & Development|April 1, 1995
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instabilityL A Donehower, L A Godley, C M Aldaz, et al.
JAMA Internal Medicine|May 22, 2013
Comparative effectiveness of intensity-modulated radiotherapy and conventional conformal radiotherapy in the treatment of prostate cancer after radical prostatectomyGregg H Goldin, Nathan C Sheets, Anne-Marie Meyer, et al.
Human Molecular Genetics|June 20, 2014
Linking the genetic architecture of cytosine modifications with human complex traitsXu Zhang, Erika L Moen, Cong Liu, et al.
Scientific Reports|December 4, 2015
TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancerChristopher G Chapman, Christopher J Mariani, Feng Wu, et al.
Stem Cell Research|February 5, 2026
Generation of an induced pluripotent stem cell line CGOi001-A from a patient with hereditary thrombocytopenia and a germline ANKRD26 mutationAubrianna S Ramsland, Karolina Dudek, Kelsey E McNeely, et al.
Pageof 32